StonvexLoading…
StonvexStonvexStonvexCore line items from CBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $121.60M | $123.21M |
Operating Income | $47.42M | $40.57M |
Net Income | $37.20M | $31.41M |
EPS (Diluted) | $2.95 | $2.54 |
Total Assets | $2.29B | $2.30B |
Total Liabilities | $2.01B | $2.08B |
Cash & Equivalents | $144.32M | $178.20M |
Free Cash Flow OCF − CapEx | $35.23M | $35.63M |
Shares Outstanding | 13.70M | 12.11M |